Featured News
![](/sites/default/files/styles/4_3_medium/public/2022/06/14/image%2059.png?itok=Ho2CIWYA)
AIM Blog
A New Era of Alzheimer’s Treatment and Care
When nearly 14,000 researchers recently joined for the Alzheimer’s Association International Conference (AAIC), the latest and greatest in Alzheimer’s and dementia research was on display. Throughout ...
All News
![Researcher with microscope](/sites/default/files/styles/4_3_small/public/2022/07/25/Researcher%20with%20Microscope.jpg?itok=4gB8Avz4)
Press Release
FDA Advisory Committee Unanimously Confirms Efficacy and Clinical Benefit of Leqembi for Early Alzheimer's Disease
CHICAGO, June 9, 2023 — Today, an Advisory Committee to the Food and Drug Administration (FDA) unanimously endorsed the efficacy...
![Mike at DC rally](/sites/default/files/styles/4_3_small/public/2023/06/02/ALZ-46.jpg?itok=XhunZRJf)
AIM Blog
Recognizing AIM’s June Advocate of the Month: Mike Razzi
Each month, we’re featuring an advocate who engages with policymakers to ensure priorities that improve the lives of people impacted...
![Man asks Doctor Question](/sites/default/files/styles/4_3_small/public/2022/08/02/AA%20Man%20asks%20Doctor%20Question.jpg?itok=CIZl-JeR)
Press Release
Alzheimer’s Association Statement on CMS Announcement of Registry for Access to FDA-Approved Alzheimer’s Treatments
The Alzheimer’s Association recognizes that the Centers for Medicare & Medicaid Services (CMS) has announced their conceptual approach to fulfill...
![First Ladies Clinton, Bush and Carter](/sites/default/files/styles/4_3_small/public/2023/05/30/phot.jpg?itok=qSNz2Tan)
Press Release
Alzheimer’s Association Statement on Announcement of Rosalynn Carter’s Dementia Diagnosis
The Alzheimer’s Association expresses our deepest appreciation to former First Lady Rosalynn Carter and her family for sharing her diagnosis...
![DC rally](/sites/default/files/styles/4_3_small/public/2023/05/26/ALZ-108.jpg?itok=UIQL03Ic)
AIM Blog
Alzheimer’s Advocates Rally for CMS to “Fix This Mess” and Stop Blocking Access to Alzheimer’s Treatments
In communities across the nation, passionate Alzheimer’s advocates put on their purple, picked up their signs and rallied for access...
![Appropriations and Research](/sites/default/files/styles/4_3_small/public/2022/06/14/image%2059.png?itok=pzhcBO-0)
Press Release
Alzheimer’s Association, Individuals Living with Alzheimer’s Urge FDA to Grant Traditional Approval for Lecanemab
CHICAGO, May 25, 2023 — The Alzheimer's Association and members of the Association's Early Stage Advisory Group submitted comments to...